BusinessWire India
Kolkata (West Bengal) [India], September 9: iKure Techsoft Private Limited in the present day introduced it has secured USD 1.8 million in Pre-Series A funding from 4 globally revered healthcare, basis and strategic buyers – Philips Foundation, World Diabetes Foundation, Bayer Foundation (facilitated by means of We Share Forward) and Prourgn LLC, Japan – every reaching the choice independently after evaluating iKure’s supply mannequin, know-how platform and talent to execute at scale. The participation of 4 globally acknowledged organizations from healthcare, philanthropy and strategic funding displays rising confidence in scalable, technology-enabled main healthcare fashions inbuilt India.
The funding lets iKure preserve displaying up for sufferers lengthy after the primary go to – not treating a check-up because the end line however staying with individuals for so long as their care truly requires. It is that this promise, greater than the spherical itself, that drew 4 unbiased buyers to the identical conclusion.
Why This Matters
India has made important progress in increasing entry to screening. The bigger problem is constructing techniques that stick with sufferers after the primary go to. Diabetes, hypertension and maternal well being problems demand ongoing monitoring, not a single check-up – and non-communicable illness is now the main explanation for demise within the nation. A analysis with out follow-up hardly ever adjustments an end result.
iKure was constructed to shut that hole: well being staff who develop into acquainted faces in a group for years, not guests passing by means of, backed by affected person information that carry ahead relatively than reset with each go to. That is what 4 buyers with completely different mandates evaluated earlier than committing capital – and why they arrived, independently, on the similar conclusion.
iKure’s Model
iKure operates throughout eleven Indian states, reaching 7,900 villages and 36 million+ individuals, with greater than 4.5 million affected person interactions recorded throughout its community. The firm runs main healthcare hubs, clinics, pharmacies, diagnostics and telemedicine providers – unified by means of WHIMS, its proprietary digital well being platform, and delivered on the bottom by greater than 400+ skilled Community Health Activists.
These items operate as one system, not separate applications. A analysis made at a healthcare hub turns into a part of a affected person file in WHIMS {that a} Community Health Activist checks earlier than knocking on that very same door weeks later. Diabetes360, iKure’s power illness administration program, applies the identical logic – routing ongoing diabetes care by means of the identical area community used for maternal well being and cardiac monitoring, so continuity, not a single specialist go to, retains a affected person’s situation managed. More than 10,000 women-led Self-Help Groups lengthen this attain into households a scientific service alone would wrestle to enter.
The mannequin has held up throughout geographies with little in widespread past the constraints they impose – from flood-prone coastal areas to landlocked terrain with very completely different infrastructure gaps. That vary, greater than any single consequence, is what this group of buyers evaluated earlier than committing capital.
How The Investment Will Be Deployed
The funding places extra well being staff on the bottom and expands iKure’s healthcare hubs, clinics, pharmacies and diagnostic capability throughout underserved areas. A major share goes into WHIMS, together with new AI-enabled scientific determination help constructed to offer area staff earlier warning of affected person danger and provides scientific groups sharper instruments for managing bigger affected person populations.
Remote affected person monitoring and workforce improvement spherical out the plan – each extensions of the identical thought already constructed into the mannequin: care that stays with individuals over time as a substitute of resetting after every go to. The funding grows iKure’s presence throughout India and deepens its scientific attain; it doesn’t open a brand new line of enterprise.
Outlook
This spherical positions iKure for its subsequent section of progress, shifting the corporate from robust regional protection towards deeper engagement with state well being techniques and nationwide well being planning. The mannequin’s core method, pairing group well being staff with longitudinal digital information, is constructed to increase past India, although the corporate’s fast precedence stays scaling its healthcare infrastructure inside the nation.
Quotes
“Every part of this investment is intended to ensure that patients remain connected to care long after their first consultation, whether that means training more health workers or sharpening what our technology can flag before a condition worsens. That accountability is what we built this company around, and it is what determines how we scale from here.”
– Sujay Santra, Founder and CEO, iKure
“Improving access to quality healthcare for underserved communities is at the heart of Philips Foundation’s mission. We invested in iKure because its model combines trusted community health networks, primary care and digital tools to keep people connected to care beyond the first consultation. We are pleased to support iKure as it scales this model and reaches more underserved communities across India.”
– Bahaa Eddine Sarroukh, Director & Head, Philips Foundation Impact Investments
“At the World Diabetes Foundation, we believe that strong primary healthcare systems are essential to improving the prevention, early detection and management of diabetes and other chronic diseases. Reaching underserved communities at scale requires solutions that are locally rooted, innovative and sustainable. iKure’s approach-combining community health activists with technology-enabled primary care-reflects that ambition. We are proud of our partnership that focuses on making quality healthcare more accessible to communities that need it most. We have been consistently impressed by the capability and dedication of the iKure team, and by their ability to combine deep community understanding with technology and innovative approaches to healthcare delivery.”
– Cansu Unalan, Project Manager, World Diabetes Foundation
“Building healthcare that actually reaches the last village is not a matter of one good idea – it takes years of listening, adjusting, and starting again. This round is recognition of that persistence. In my own career, running operations across Asia, the hardest part was never the technology – it was the last mile. That is precisely what iKure has built: trusted health workers, community clinics, and the follow-through that makes technology actually work in a village. Japanese companies are looking very closely at India today, and I hope to help connect them with what iKure has built here. I am proud to walk alongside them, and I believe the most important part of iKure’s work is still ahead.”
– Rieko Yano, Founder and CEO, Prourgn LLC
“Congratulations to iKure on this important milestone. At We Share Forward, we’re especially proud of the role we’ve been able to play as a facilitator and catalyst in bringing renowned partners like the World Diabetes Foundation and Bayer Foundation into this Pre-Series A round alongside us – mobilizing this kind of collective, high-caliber philanthropic capital is exactly the impact we exist to create. Beyond the funding itself, we’re inspired by what it will help iKure achieve: strengthening its frontline health worker network and expanding access to diabetes and non-communicable disease care for more underserved communities across India. We’re proud to stand behind Sujay and the entire iKure team, and we look forward to a strong partnership as this next chapter unfolds.”
– Mariano Larena, Managing Director, We Share Forward (Switzerland)
“Health equity starts in communities. Through trusted local health workers and accessible primary care, iKure is expanding quality healthcare for underserved populations. We are proud to support this innovative model and its mission to improve health outcomes for those who need it most.”
– Stefan Wilhelm, Director, Social Innovation & Head LATAM & Africa, Bayer Foundation
The Pre-Series A funding positions iKure to strengthen its technology-enabled main healthcare platform, develop its scientific infrastructure and lengthen steady, community-based care to extra underserved populations throughout India. As the corporate enters its subsequent section of progress, its focus stays unchanged: constructing a healthcare system that stays related to sufferers lengthy after the primary go to.
(ADVERTORIAL DISCLAIMER: The above press launch has been supplied by BusinessWire India. ANI won’t be accountable in any approach for the content material of the identical).